State health ministries, which administer
vaccines, have ordered 26.3 million emergency doses since December, but some places still
ran short.
While this approach has had some clinical success, in most cases, the immune response resulting from dendritic cell
vaccines is
short - lived and not robust enough to keep tumors at bay over the long
run.